Overview

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Status:
Completed
Trial end date:
2018-01-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of BMS-986004 when administered in subjects with ITP.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb